Skip to Main Content

Immunic, Inc. Common Stock

IMUX Real Time Price USD
1.20
-0.06
(-4.83%)
As of today at 06:04 UTC-04:00 (Market Closed)
Add to Watchlist
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of IMUX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
IMUX Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
IMUX Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
IMUX Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes by institutional investors

Quarterly net insider trading by IMUX's directors and management

Government lobbying spending instances

  • $10,000 Jan 20, 2022 Issue: None
  • $20,000 Jan 20, 2022 Issue: None
  • $10,000 Oct 20, 2021 Issue: None
  • $20,000 Oct 20, 2021 Issue: None
  • $20,000 Jul 20, 2021 Issue: None
  • $20,000 Apr 20, 2021 Issue: None
  • $20,000 Jan 20, 2021 Issue: None
  • $10,000 Jul 20, 2020 Issue: Health Issues Medical/Disease Research/Clinical Labs Science/Technology
  • $10,000 Jul 17, 2020 Issue: Medical/Disease Research/Clinical Labs

Estimated quarterly lobbying spending

IMUX Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
IMUX Income Statement
IMUX Balance Sheet
IMUX Cash Flow
U.S. Patents

New patents grants

  • Patent Title: Vidofludimus for use in the treatment or prevention of viral diseases Dec. 17, 2024
  • Patent Title: Calcium salt polymorphs as anti-inflammatory, immunomodulatory and anti-proliferative agents Jul. 16, 2024
  • Patent Title: Compounds and dosage regimen for use in the prevention or treatment of chronic inflammatory and/or autoimmune diseases Jan. 23, 2024
  • Patent Title: Treatment of multiple sclerosis comprising dhodh inhibitors Jan. 23, 2024
  • Patent Title: Vidofludimus for use in the treatment or prevention of viral diseases Jul. 05, 2022
  • Patent Title: Il-17 and ifn-gamma inhibition for the treatment of autoimmune diseases and chronic inflammation Apr. 05, 2022
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
IMUX News

Recent insights relating to IMUX

WallStreetBets

Number of mentions of IMUX in WallStreetBets Daily Discussion

CNBC Recommendations

Recent picks made for IMUX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IMUX

IMUX Analyst Ratings

IMUX Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
IMUX Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $IMUX stock a Buy, Sell, or Hold?

  • What is the price target for $IMUX stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

IMUX Top Shareholders
Shareholder
Shares Held
IMUX Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $IMUX stock?

  • Who owns the most shares of $IMUX stock?

  • What funds own $IMUX stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

IMUX Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view IMUX Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top